Differences in clinical outcomes of COVID-19 among vaccinated and unvaccinated kidney transplant recipients
- 27 April 2022
- Vol. 40 (24) , 3313-3319
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Effectiveness of an Inactivated SARS-CoV-2 Vaccine in ChileNew England Journal of Medicine, 2021
- Two Doses of SARS-CoV-2 Vaccines Reduce Risk of Death Due to COVID-19 in Solid Organ Transplant Recipients: Preliminary Outcomes From a UK Registry Linkage AnalysisTransplantation, 2021
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infectionNature Medicine, 2021
- Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control studyBMJ, 2021
- Antibody Response to 2-Dose SARS-CoV-2 mRNA Vaccine Series in Solid Organ Transplant RecipientsJAMA, 2021
- Safety and Reactogenicity of 2 Doses of SARS-CoV-2 Vaccination in Solid Organ Transplant RecipientsTransplantation, 2021
- Effectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks — Connecticut, December 2020–February 2021MMWR. Morbidity and Mortality Weekly Report, 2021
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineNew England Journal of Medicine, 2020
- COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaborationNephrology Dialysis Transplantation, 2020
- Use of tocilizumab in kidney transplant recipients with COVID-19American Journal of Transplantation, 2020